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Rather early in studies on influenza immunization in animals as well as in 
man, it was realized that immunizing effect, as reflected in antibody response 
induced by the vaccines employed, was limited and of relatively short duration. 
For these reasons  (1)  a  variety of methods were explored for enhancing and 
prolonging the protective effect induced by vaccination (2-7). None, however, 
provided such striking results as those obtained in studies in animals reported 
by Friedewald  (6), and in  studies in man reported by Henle and  Henle (7). 
These investigators used vaccines consisting of virus in water-in-oil emulsions 
in the manner developed in recent years by Freund (8). 
Although the immunologic data derived by Friedewald and the Henles were 
outstanding,  in  comparison  to  the  effects induced  by vaccines consisting of 
virus in an aqueous medium alone, the immunologic success was blighted by 
the occurrence of undesirable reactions at the site of inoculation. The problem 
remaining after these experiences seemed merely to be one of reducing or elimi- 
nating the untoward local reaction while retaining the immunologic advantage. 
That this could be accomplished was evident from observations made, in the 
course of certain other studies (9), when it was found that rather large doses of 
water-in-oil emulsions without acid-fast bacilli could be  inoculated  into mon- 
keys without untoward local reactions. In the studies referred to reagents were 
used which were different from those employed by Friedewald and the Henles 
and  the inoculum was  introduced intramuscularly  rather  than  subcutaneously. 
When  influenza  virus  vaccine  was  prepared  in  this  particular  water-in-oil 
emulsion and administered to monkeys intramuscularly, it too could be given 
without producing undesirable effects at the inoculation site. 
* This investigation was conducted under the auspices of the Commission of Influenza, 
Armed Forces Epidemiological  Board, and supported by the Orifice  of The  Surgeon Gen- 
eral, U. S. Army, Washington, D. C. 
~: Part of the material contained in this report was presented in partial fulfillment  of the 
requirement for Master of Science  degree, University of Pittsburgh. 
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The absence of reactions and the high levels of antibody induced in animals 
inoculated with virus emulsified with the agents to  be described prompted a 
series of experiments to determine the degree and duration of the immunologic 
effect; for theoretical as well as practical considerations it was of interest not 
only to determine the height and persistence of the increased antibody titer, 
but to know as well how small a quantity of antigen when incorporated with the 
adjuvant would still be effective in inducing antibody formation.  It seemed 
important, too,  to  study the  course of  development of antibody activity as 
measured by different methods,  i.e., hemagglutination inhibition, virus  neu- 
tralization,  and  complement fixation,  to  gain  further  information regarding 
the relationship among these three activities of the serum of vaccinated animals. 
The results to be presented will indicate that the vaccine employed could be 
diluted approximately lO0,O00-fold and, when incorporated with mineral oil, 
was still effective in inducing antibody formation; vaccine without mineral oil 
was ineffective in this respect when diluted lO0-fold; and, it was found that the 
antibody activities measured by the three different methods develop and de- 
cline at different rates. 
Materials and Methods 
Vaccine.--The vaccine used in these studies contained the PR8 strain of influenza virus 
type A; it had been prepared by a manufacturer of biologicals  especially for use in field studies 
by the Commission on Influenza (10). The method of preparation involved sedimentation by 
Sharpies centrifugation of virus from allantoic fluid of infected chick embryos; the virus was 
then resuspended to a concentration of 400 CCA  1  units per ml. (11). Infectivity  was destroyed 
by treatment with 1:2000 dilution  of formalin. When used in the experiments to be described, 
the vaccine had been stored at 1-4°C. for approximately 2 years. 
Emulsif~ation with Mineral 0//.--The mineral oil used in these experiments is known as 
hayol F and was obtained from Esso Standard Oil Company, Philadelphia. The emulsifying 
agent is referred to as arlacel A; the latter is the trade name for mannide monooleate and was 
supplied by The Atlas Powder Company, Wilmington, Delaware. Both reagents have been 
used by Freund and his associates (12) and in the studies referred to above (9). In the initial 
experiments, the oil and the emulsifying agent were sterilized separately in the autoclave, for 
15 minutes, at a pressure of 15 pounds and at 120°C. Subsequently these reagents were mixed 
prior to sterilization in a ratio of 9 parts of hayol F to 1 part of arlacel A. Undiluted  vaccine 
or the desired dilution made in buffered physiologic salt solution containing 0.05 ~ phosphate 
buffer, pH 7.3, was mixed with the oil and  emulsifying agent in the ratio  of 10:9:1. The 
aqueous phase was added dropwise to  the other two reagents, contained in a mortar,  and 
blended with the pestle. Homogenization was accomplished by repeated filling and forcible 
ejection from a 10 cc. Luer lock syringe fitted with an 18 gauge needle, 1/4 inch in length. It 
usually required 10 to 15 minutes of mixing to effect complete emulsification; this was in- 
dicated when a drop of the viscous mixture placed on the surface of water in a beaker or paper 
cup remained discrete. The mixture was inoculated usually within an hour after preparation 
although this is not necessary since the emulsion and the antigen contained therein are quite 
stabile. Emulsification for the preparation of material tested in humans, to be reported separ- 
ately, was effected in a closed system by means of a syringe and 17 to 18 gauge needle in- 
serted into the diaphragm of a vaccine vial, 
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Experimental Animals, Methods of Inoculation, and Bleeding.--Rhesus  monkeys, weighing 
from 5 to 8 pounds, used in these studies were healthy, non-paralyzed survivors of studies on 
poliomyelitis. In preparation for injection, the skin over the calf of the left leg was shaved and 
cleansed with tincture of iodine. A 22 gauge needle, 1½ inches in length, was fitted to a 2 ml. 
Luer lock syringe for injection of the 1 ml. dose and to a  0.5 ml. tuberculin syringe which 
was used for injection of the 0.1 ml. dose. In each instance, approximately 0.5 ml. of air was 
drawn into the syringe so as to force the inoculum through and avoid loss of material that 
would otherwise remain in the needle. Groups of three or four monkeys were inoculated with 
each mixture of emulsified vaccine or vaccine in saline; observations were made for evidences 
of local reaction and blood samples were obtained at intervals indicated in the text. Bleedings 
of 5  to  10 ml. were made from the femoral vessels; animals were anesthetized lightly with 
ether or by intraperitoneal injection of 5 per cent sodium pentobarbital, employing a dose of 
0.2 ml. per pound. All serum samples were handled aseptically and stored at 1-4°C. 
Methods Employed for the Serologic Tests.--In the investigations here reported, immunologic 
methods  embodying three different principles were  used:  (a)  hemagglutination inhibition, 
(b) virus neutralization in o~o, and (c) complement fixation. 
Hemagglutination Inkibition.--The method for determining the quantity of hemagglutina- 
tion-inhibiting substance has been described  (13).  The virus used as antigen was prepared 
from allantoic fluid of embryonated eggs, infected with the same seed virus used in the prepara- 
tion of the vaccine. Eggs were inoculated on the  10th or  llth day of incubation and  the 
antigen derived after 48 hours of further incubation at 35°C.  Storage was at 1-4°C. and the 
titer of hemagglutinating activity determined immediately prior to and  at  the time of its 
use in the serologic test. Sera tested by this method were heated at 56°C.  in a water bath for 
30 minutes; serial twofold dilutions in physiologic solution of sodium  chloride were  made 
using a  separate pipette for each dilution. Dilutions were prepared in test tubes and 0.5 ml. 
of each transferred to a  plastic plate (14). To each dilution was then added 0.25 ml. of the 
antigen containing a  sufficient amount  of material so  that 4  hemagglutinating units were 
present in the final mixture and to the serum-virus mixture was then added 0.25 ml. of I per 
cent chicken red blood cell suspension. The end-point was considered to be the highest dilu- 
tion of serum that completely inhibited the hemagglutinating effect of the virus. The results 
are expressed here as the final dilution of serum in the mixture. The sera from monkeys in 
any one vaccinated group were tested simultaneously and when it was necessary to relate the 
results of tests on different days, a pool of human immune serum was included as a standard 
for comparison. 
Virus Neutralization  Test in Ovo.--For this purpose, a pool of virus contained in allantoic 
fluid of infected chick embryos was distributed in glass ampules, sealed, and stored at --?0°C. 
Prior to use in the serologic test the 50 per cent embryo infectious dose (EIDs0)  was deter- 
mined; infection in the embryo was indicated by the presence of hemagglutinin in allantoic 
fluid of embryos inoculated by this route. Serum dilutions were made in beef heart infusion 
broth containing 100 units of penicillin and I000 ktg. of streptomycin per ml. to reduce the 
likelihood of bacterial contamination; sera with low levels of  antibody,  as  determined by 
preliminary test,  were  diluted  in  fourfold  steps;  those with high levels of  antibody were 
diluted in tenfold steps. Serum-virus mixtures consisting of equal volumes  (0.5  ml.)  of the 
respective dilutions of serum and of diluted virus containing approximately 2000 EID~ were 
incubated in a  water bath at 37°C.  for 30 minutes prior to inoculation of 0.1 ml. volumes 
into the allantoic sac of each of five 10 day old embryos. Incubation was continued at 35°C. 
for 2 more days and the eggs candled to recognize embryos that had died following inocula- 
tion; after refrigeration at 4°C.  overnight, allantoic fluid was removed  from each egg and 
tested for the presence of hemagglutinating substance by the addition of an equal volume 
(0.5  ml.) of 0.5 per cent chicken red cell suspension. Neutralization of infectious activity of 
the  virus by  serum  was  indicated  by  the  absence  of  hemagglutination.  The  neutralizing 
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serum-virus mixture that would result in infection of 50 per cent of the embryos as calculated 
by the method of Reed and Muench (15). 
Complement Fixation Test.--The  method employed for testing complement-fixing  activity 
is essentially the same as that in general use. The antigen used was the same one used in the 
other  serologic tests.  A 1:10 dilution of infected allantoic fluid was used as antigen after 
different quantities of the virus suspension were tested against twofold dilutions of antiserum 
of high titer to determine the optimal quantity of antigen for a test employing 4 hemolytic 
units of amboceptor, 1 full unit of complement, and a 1 per cent suspension of sensitized sheep 
red blood cells. The serum was heated in a water bath at 56°C., for 30 minutes, and then 
diluted serially in saline in twofold steps from 1:8 to 1:8192. Two identical series of serum 
dilutions were set up; to the first was added an equal volume of a 1:10 dilution of the virus 
antigen and to the second set was added a similar quantity of allantoic fluid from uninfected 
embryos. Suitably diluted complement was then added in a volume of 0.2 ml. After overnight 
incubation in the cold room at 1-4°C., the reaction mixtures were then placed in a 37°C. 
water bath for 10 minutes, 0.4 ml. of sensitized sheep red cell suspension added, and incuba- 
tion continued for an additional 30 minutes. The test was read immediately and a positive 
reaction was considered to be one in which complete fixation of complement occurred; the 
end-point is expressed in terms of the initial dilution of serum before the  addition of the 
reagents. 
EXP]~RIM~NTAL 
In this section will be described the reactions observed and the immunologic 
findings in two experiments performed in groups of monkeys that were studied 
for a  period of 1 year after inoculation or for as long as  they survived within 
that interval. The essential distinction between the two experiments is the size 
of the inoculum; in the first a  1 ml. inoculum was used  and in the second the 
volume administered was 0.1 ml. In each instance equal quantities of adjuvant 
(oil +  emulsifying agent) and aqueous phase were  blended together. As indi- 
cated in Tables I  and II, the quantity of antigen contained in the respective 
doses of virus used in each experiment was  varied over different ranges; the 
opposite  extremes  for  the  two  experiments together  are  100,000-fold  apart. 
The immunologic data are presented in full in  Tables I, II, and III; and, for 
particular emphasis, selected portions have been put  in graphic form in Figs. 
1 to8. 
In the experiment in which a 1 ml. inoculum was used, the vaccine was diluted in half- 
log steps; emulsified  mixtures were prepared with the undiluted material and with the various 
dilutions through and including 10  -2. In the second experiment, in which 0.1 ml. was inocu- 
lated, tenfold dilutions of vaccine from undiluted to 10  -4 were emulsified with mineral oil; 
groups of three or four animals were used in each experiment. Thus, monkeys of the second 
experiment that received the 0.I  ml. dose of the undiluted  vaccine mixed with adjuvant 
received the same amount of antigen as did animals in the first experiment given a 1 ml. dose 
made up of the  10  -I dilution of vaccine plus adjuvant; similar overlapping of dosages of 
antigen used in the two experiments also occurred in groups given the next higher tenfold 
dilution in each series. The data obtained in these particular groups will be compared in the 
charts to follow. 
Observations  on the Site of Inoculation.--In no instance was it possible to dis- 
tinguish by inspection or palpation between corresponding sites in uninoculated TABLE I 
gemagglutination  Inhibition  Antibody  liters in Serum  of Individual  Monkeys  at Intervals after 
Vaccination with Diminishing  Quantites of Virus Combined with Adjuvant 
Vaccine  Interval 
(1.0mL  ]  post 
intramus-  vaccl- 
__cularly)  __nati°n 
Before 
1 wk. 
2 wks. 
4 wks. 
Virus  5 wks. 
+  j  2 mos. 
I 
adjuvant  [  3 mos. 
4 mos. 
6 mos. 
9 mos. 
12 mos. 
Before 
1 wk, 
2 wks. 
4 wks. 
Virus  6 wks. 
+  2 mos. 
saline  3  mos. 
4  mos. 
5  mos. 
• 9  mos. 
12 mos. 
Quantity of stock vaccine incorporated in inoculum* for each group 
0.50 ml.  0.16 ml.  0.08 ml.  0.015 ml.  0.005 ml. 
0  0  0 
256  256  256 
2048  2048  2048 
2048  2096  4096 
8192  32,000  8192 
16,000  65,000  16,000 
0 
15 
64 
128 
128 
128 
64 
64 
64 
64 
64 
D  65,000  32,000 
32,000  32,000 
0  0  0 
512  256  64 
2048  4096  512 
8192  4096  1024 
8192  9182  1024 
16,000  16,000  D 
65,000  16,000 
65,000  8192 
0  0  0 
0  16  16 
512  1024  1024 
512  1024  2048 
2048  2048  2048 
t095  1024  2048 
t096  1024  2048 
t096  512  2048 
0  0  0 
0  0  0 
256  256  522 
256  512  512 
256  812  812 
1024  512  512 
1024  512  1024 
512  512  1024 
15,000  16,000  32,000 
D  16,000  16,000 
8192  8192 
0  0 
16  8 
64  64 
128  8 
128  8 
64  8 
64  D 
64 
64 
64 
D 
4096 
2048 
1024 
t096 
D 
0 
8 
64 
64 
D 
D  2048 
2048 
1024 
0  0 
16  0 
32  16 
32  16 
8  16 
8  16 
D  16 
16 
8 
0 
0 
512  512  1024 
512  256  1024 
256  256  512 
0  0  0 
0  0  0 
2048  512  1024 
2048  1024  1024 
2048  1024  512 
2048  1024  D 
4095  512 
2048  512 
2048  256 
1024  256 
D  128 
* Containing mixture of equal parts of the virus dilution and adjuvant. 
0  =  <8; D  =  monkey died. 
TABLE  II 
Hemagglutination Inhibition  Antibody  Titers in Serum  of Individual  Monkeys  at Intervals a£ter 
Vaccination with Diminishing  Quantities of Virus  Combined wifh Adjuvant 
Vaccine 
(0.1 mL  Interval 
intramus-  post vacci- 
cularly)  nation 
Before 
1 wk. 
2 wks. 
Virus +  ad-[  4 wks. 
i 
juvant  I  6 wks. 
] 
I  2 mos. 
3 mos. 
4 rues. 
Before 
1 wk. 
2 wks. 
Virus +  4 wks. 
saline  6 wks. 
2 mos. 
3 mos. 
4 mos. 
Quantity of stock vaccine incorporated in inoculum* for each group 
0.05 mL  0.005 mL  0.0 005 mL  0.00005 ml.  0.000005  ml. 
0  0  0 
32  32  32 
512  286  512 
1024  1024  1024 
1024  2048  2048 
1024  1024  2048 
812  1024  D 
512  1024 
0  0  0  0 
0  128  128  128 
0  128  512  128 
0  i28  256  64 
0  64  128  64 
0  64  128  32 
0  64  64  32 
0  64  64  16 
0  0  0 
0  64  32 
64  256  128 
128  512  512 
512  512  1024 
812  256  4096 
1024  256  4096 
512  128  8192 
0  0  0  0 
128  0  32  8 
32  0  256  16 
16  0  32  8 
8  0  16  8 
0  0  0  0 
0  0  0  0 
0  0  0  0 
0  0  0  0 
64  0  0  0 
256  64  64  128 
512  128  128  128 
1024  256  64  128 
512  128  64  128 
512  128  64  128 
256  64  64  128 
0  0  0  0 
0  0  0  0 
16  0  0  16 
32  16  32  32 
32  32  64  64 
32  16  64  64 
32  16  64  64 
32  86464 
0  0  0  0 
0  0  0  0 
8  8  0  0 
16  32  0  8 
32  64  8  8 
32  64  8  8 
16  128  0  16 
16  64  0  8 
* Containing mixture of  equal parts of  the  virus dilution  and adjuvant. 
0 =  <8; D  =  monkey died. 
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as compared with inoculated limbs in which either the 1 ml. or the 0.1 ml. dose 
was given. In the  course of this  and other experiments  several animals died 
and at autopsy the inoculation site of the injected muscle was dissected for gross 
and microscopic examination. Depending in part upon the interval post vacci- 
nation,  frequently the material injected could not be found in animals given 
the small dose; with the larger dose, however, it was easy to recognize the white 
emulsion distributed  in  fine  droplets over wide  areas,  particularly along the 
muscle fibers.  There was no gross evidence of acute inflammation; the droplets 
TABLE III 
Comparison of Antibody  Titers Determined by  Three Different Methods in One Monkey 
Vaccinated with Virus +  Adjuvant and in Another Vaccinated with Virus +  Saline 
PR8 virus -{- adjuvant*  PR8 virus -{- saline~ 
Interval post 
Hemag-  Complement  Complement  vaccinatlon  Virus  glutination 
neutralization  inhibition  fixation  fixation 
Before 
1 
2 
4 
6 
8 
12 
16 
26 
39 
52 
0.0 
0.9 
2.2 
2.5 
4.1 
4.3 
5.2 
5.3 
5.2 
5.1 
4.9 
0.0 
2.1 
3.0 
3.3 
3.6 
3.9 
4.2 
4.2 
3.9 
3.9 
3.9 
0.0 
0.0 
1.2 
1.5 
2.1 
2.5 
2.9 
2.9 
2.4 
2.4 
2.1 
Hema~ o 
Virus  glutinatlon 
neutralization  inhibition 
0.0  0.0 
0.6  0.9 
0.6  1.5 
1.6  1.8 
2.5  1.8 
2.5  1.8 
2.5  1.5 
2.5  1.5 
2.5  1.5 
2.4  1.5 
2.2  1.5 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
Numerals represent negative log10 of serum dilution end-points expressed as the dilution 
of serum before the  addition of other reagents incorporated in the serologic test. 
* 1.0 ml. Intramuscularly of emulsion of equal parts of undiluted vaccine Jr- mineral oil 
adjuvant. 
:~ 1.0 ml. Intramuscularly of mixture of equal parts of undiluted vaccine -{- saline. 
of emulsion  were  free  and  not  bound  by exudate.  Microscopic examination 
revealed  dense aggregates of mononuclear cells,  the  great majority of which 
were lymphocytic in appearance. 
The observation that the inoculum was dispersed from the site of injection~ 
presumably  the  result  of  muscular  action,  was  especially  pertinent  to  the 
original purpose of these experiments. It was observed that neither the oil, the 
emulsifying agent, nor the antigen appeared to be irritating; there was, there- 
fore, ample opportunity for the emulsion injected to be dispersed into many 
small loci rather than be walled off by an immediate acute inflammatory re- 
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muscularly, is in contrast to the tendency for it to remain as deposited when 
introduced  subcutaneously.  Under the latter circumstances,  the inoculum be- 
comes the content of a thin walled cyst, the lining of which is composed of the 
type  of  cellular  reaction  described  above.  Histologic  studies  on  sections  of 
muscle removed at intervals following inoculation will be reported in detail at 
a  later date. 
Immunologic Data.--All serum samples obtained at intervals following vac- 
cination were tested for hemagglutination-inhibiting antibody; the data shown 
in Tables I and II, respectively, contain the results of the experiments with a  1 
i~oo 
2048- 
512- 
64- 
32. 
16" 
8- 
A  A 
° 
/S  - 
/  //~",  f.o ml. CONTAINING  EQUAL PARTS 
d  ",,.~  m,  /  I  "'"  ..~  3 ~ffemm  moe~e~ 
<8" 
o  "  ~  '  ~  ~  ~  ~b  i~ 
WEEKS  POST  VAGCANATION 
Fro.  1.  Level of serum antibody  at intervals post  vaccination  in  monkeys inoculated 
intramuscularly with influenza A virus vaccine (PR8) mixed with mineral oil adjuvant  or 
with saline. 
ml. inoculum or a 0.1  ml. inoculum containing the different quantities of anti- 
gen.  When one compares the course of development of antibody in monkeys 
that had received corresponding quantities with or without the adjuvant, it is 
clearly  evident  that  much  higher  levels of antibody  are  induced  in  animals 
injected with the water-in-oil  emulsion  as  compared  with  those  that  receive 
the  vaccine without  oil.  Not only did  the  titers  of antibody reach  the  high 
levels indicated but there was only a  slight tendency toward  decline in  the 4 
to 12 month interval post vaccination. 
A curve is shown in Fig. 1 indicating the  course of antibody development in 
three monkeys during the first 12 weeks  following injection of the  1 ml. dose 
containing undiluted  vaccine  plus adjuvant;  for comparison, curves for mon- 
keys inoculated with a corresponding quantity of antigen mixed with saline are 436  ADJITVANTS IN INFLUENZA IMMUNIZATION 
also shown. In one of the three monkeys given the latter material, the level of 
antibody rose to a  maximum of 1:64 at the 2 week period and then declined 
promptly. In the other two monkeys given virus in saline, the peak was reached 
in 4 weeks and the decline from a high of  1:128 became evident by the 12th 
week. This is in contrast to the continuing rise, sharply at first and then more 
gradually to levels of 16,000 to  65,000  at 8 to  12 weeks post vaccination in 
animals inoculated with virus plus adjuvant. 
The data contained both in Tables  I and II suggest that the maximal anti- 
body level achieved diminishes as the quantity of virus contained in the inocu- 
16,0001 
8,1921 
~04ei 
°:t: 
16 
.: 
VOL. IN 1~4..OF 
STOCK VACCINE 
W INO~JLUM 
as x ~  ~ 
0.5 x10  "t 
WEEI~5  POST  VJU~ATION 
Fro.  2.  Comparison of  course of antibody development in monkeys inoculated  intra- 
muscularly with  vaccines containing  mineral oil adjuvant and different quantities  of the 
nflnenza virus antigen (PRS). 
i 
lure is reduced. Before presenting a  composite chart to illustrate the relation- 
ship between quantity of virus injected and level of antibody induced, it is 
desired to present the set of curves shown in Fig. 2 indicating the course of 
antibody development in the first 12 weeks in monkeys inoculated with a I mh 
dose of emulsions containing different quantities of virus. These curves repre- 
sent the best fit through the points for the three animals in each group given 
vaccines containing quantities of antigen that differed by tenfold steps. The 
data presented in Fig. 2 are intended merely to emphasize that relatively small 
doses of antigen, when incorporated with mineral oil, induce antibody forma- 
tion described by curves similar to those drawn for vaccines containing much 
larger quantities of virus. It is of interest to note the different shapes of the 
curves in the early period post vaccination, especially with respect to the delay JONAS  E.  SALK  AND  ANGELA  M.  LAURENT  437 
in appearance of antibody following injection of the smaller doses. Data are 
insufficient at this time to warrant more than calling attention to the difference 
in the slope of the later part of the curve of antibody development in monkeys 
given the largest quantity of antigen as compared with the slopes of the curves 
describing the effect of the two smaller dosages. 
Antibody  Response to the Same Quantities  of Antigen  Contained in Different 
Volumes of Emulsion.--In  the  two experiments performed with graded dilu- 
tions of virus, groups of animals were inoculated with volumes that differed 
by  tenfold, i.e.,  1.0  ml. of emulsion or 0.1  ml. At two levels, corresponding 
-  ~oz~  s~~ ~'--  o 
~s61  /o 
i! :t 
° :!t_J 
<e}~SD  • 
?  • 
eo  .o 
o 
WEEKS  POST  VACCIN&llON 
FIG. 3. Comparison of levels  of serum antibody at intervals  post vaccination in monkeys 
inoculated intramuscularly with corresponding amounts of influenza virus  vaccine (PR8) 
contained in  1.0  ml. or  0.I ml.  of  an  emulsified  mixture  of  equal parts  of  adjuvant  and aqueous 
phase. 
quantities of antigen were contained in the two different sized inocula. In all 
instances, however,  the proportion of aqueous  phase  to oil and emulsifying 
agent was the same. From the data shown in Fig. 3, in which the two different 
doses are compared both containing the equivalent of 0.5  X  10  -1 ml. of the 
stock vaccine, it is evident that the antibody response to 1.0 ml. or 0.1 ml. of 
emulsified vaccine cannot be distinguished when both inocula contain the same 
amount of antigen in the total volume inoculated. This conclusion gains further 
support from the data presented in Fig. 4  to be described in the section to 
follow. 
Relationship  between Concentration of Antigen  in  Virus-Adjuvant  Mixtures 
and Quantity  of Antibody  Induced  in  Vaccinated Monkeys.raThe relationship 438  ADJUVANTS  IN  INFLUENZA  IMMUNIZATION 
between the quantity of virus injected into monkeys and  the resulting titer 
of serum  antibody is  illustrated  in  Fig.  4;  the  influence of  the  amount of 
oil with which the antigen is incorporated is also illustrated in this figure. The 
antibody level for each monkey, 8 weeks post vaccination, is charted in relation 
to the quantity of antigen contained in the different inocula employed. The 
parallel sloping lines through the highest and lowest antibody levels induced by 
the different doses of vaccine are used to indicate the limits of variation in the 
relationship between quantity of antigen and degree of antibody response. The 
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FIG.  4.  Relationship between quantity of virus injected and titer of serum antibody in 
monkeys 8  weeks after inoculation of influenza A  virus vaccine (PR8)  mixed with mineral 
oil adjuvant.  Comparison of results in animals inoculated with  1.0  ml.  and 0.1  ml.  intra- 
muscularly. 
slope of the area between the two lines is such that a  1000-fold difference in 
mean antibody level, induced by the extremes of dosage employed to construct 
Fig. 4,  resulted from a  difference of 100,000-fold in the quantity of virus ad- 
ministered; thus, a  1000-fold difference in quantity of antigen injected can be 
expected to influence the mean antibody level only 10-fold. 
From Fig. 4 it is again evident that virus in saline was less antigenic than 
virus emulsified with the mineral oil. The stock vaccine, when diluted more than 
tenfold, and administered without adjuvant, resulted in little or no antigenic 
response  so  that hemagglutination-inhibiting antibody was not detectable 8 
weeks post vaccination; in contrast, the same virus suspension when emulsified JONAS E. SALK AND  ANGELA  tg. LAURENT  439 
with mineral oil before inoculation into monkeys induced a measurable amount 
of antibody after dilution as much as 100,000-fold. 
In the discussion of the data in Fig. 3,  it was pointed out that equivalent 
quantities of antigen when emulsified with mineral oil induced corresponding 
levels of antibody even though  administered in  volumes  that differed by as 
much as tenfold. Thus, a small inoculum of emulsion containing concentrated 
virus is as effective in inducing and maintaining antibody formation as a  large 
inoculum of an emulsion made with less concentrated antigen. This is further 
supported by the additional data in Fig. 4 which reveal the correspondence of 
1.0 ml. or 0.1 ml. of emulsion containing 0.5 X  10  -2 ml. of the stock vaccine as 
well as the 1.0 or 0.1 ml. volumes of the 0.5 X  10-1 ml. dose. Furthermore, the 
straight-line  relationship  throughout  the  entire  range  represented  in  Fig.  4 
indicates the independence of volume of inoculum within the  limits of 1.0 ml. 
to 0.1 ml. of emulsion. It should be recalled that the ratio of the aqueous phase 
to the other ingredients was constant.  The principal variables were concentra- 
tion of antigen contained in the aqueous phase, and volume of inoculum. It will 
be of interest to explore further the limits of this relationship but from a prac- 
tical point of view it is noteworthy that a very small inoculum may be employed 
provided that it contains a sufficient amount of effective antigenic substance. 
Comparison o/ Antibody  Titers  Measured by  tlemagglutination  Inhibition, 
Virus Neutralization in Ovo, and Complement Fixation.--It seemed important 
to establish whether or not the effect of the adjuvant upon the titer of antibody 
measured with the hemagglutination inhibition reaction had a  corresponding 
influence upon the antibody measured by virus neutralization in ovo, and by 
complement fixation. Accordingly, all of the serum samples available from one 
monkey inoculated with 1 ml. of undiluted vaccine mixed with adjuvant were 
tested for titer of antibody by all three methods. Similar tests were performed 
on all serum samples of one monkey vaccinated with the same amount of virus 
mixed with saline.  The data for both monkeys are shown in Table III and 
curves describing  the development and persistence of antibody measured in 
the three different ways are shown in Fig. 5. It is clear that the adjuvant effect 
was evident with the virus neutralization and the complement fixation test as 
well as the hemagglutination inhibition test. It appears from the pair of animals 
involved in the present study that the virus-adjuvant mixture induced titers of 
virus-neutralizing  antibody  and  hemagglutination-inhibiting  antibody  that 
persisted at levels approximately 1000-fold higher than those induced by the 
corresponding amount of virus in saline. In some animals inoculated with the 
more concentrated virus suspension and adjuvant, minimal quantities of com- 
plement-fixing activity were detected in tests employing normal allantoic fluid 
as antigen.  The titer for influenza antibody was  so very much higher as  to 
obviate any difficulty in interpretation. 
Although complement-fixing antibody was readily demonstrable in the serum 44O  ADJUVANTS  IN  INFLLT£NZA TM'M'UNIZATION 
of the monkey given virus fortified with adjuvant, this antibody was not found 
in the serum of the monkey given virus in saline. The highest complement-fixing 
titer that appeared in the virus-adjuvant vaccinated monkey was approximately 
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1:1000; it was essentially zero in the virus-saline  vaccinated animal.  Since the 
difference between titers for hemagglutination-inhibiting and virus-neutralizing 
activity in monkeys vaccinated with virus and adjuvant or virus and saline was 
approximately  lO00-fold,  it  would seem that  failure  to  detect  complement- 
fixing antibody in the monkey vaccinated with virus in saline  may have been 
due to quantitative factors related to the relative sensitivity of the complement JONAS  F..  SALE  AND  ANGELA  M.  LAURENT  441 
I 
fixation system for measuring antibody as compared with the other two meth- 
ods. However, it is also possible that all three activities are different and that 
qualitative  factors are  responsible  for  the  quantitative differences that  are 
observed. Although considerably more  evidence is needed to support one hy- 
pothesis  or'  another  to  explain  the  relationship  of  the  antibody  activities 
measured by the three different methods, it is of interest to examine in greater 
detail the data derived in these experiments as they may bear upon the question 
of relationship of the three antibody activities. 
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Fro. 6. Comparison of curves showing development and persistence over 1 year of antibody 
measured by virus neutralization (in ovo), by hemagglutination  inhibition, and by comple- 
ment fixation  in a monkey vaccinated with virus -}- adjuvant. 
Curves describing the  development  and persistence  of the three different 
antibody activities in the serum of the virus-adjuvant vaccinated monkey are 
shown together in Fig. 6.  It is obvious that at about the 6th week post vacci- 
nation there is a crossing of the curves describing the development of hemagglu- 
tination-inhibiting antibody activity and  virus-neutralizing activity.  In  the 
early period the hemagglutination-inhibiting titer of  the serum has a  higher 
value than the virus-neutralizing titer and in the later period the reverse is true. 
Even though numerical values for complement-fixing titers are lower than for 
the other antibodies, it appears that the curve expressing the development of 
complement-fixing antibody does not parallel either of the other two curves. 
In order to determine the trend and the significance of the apparent differ- 
ences in the rates of development of the three antibody activities, a factor was 442  AD]I~TANTS  IN INFLUENZA  IMMUNIZATION 
derived for  expressing  the  difference between  the  titers  of  serum  antibody 
activity measured by two methods; the factor merely represents the difference 
between the log values for the two serum antibody titers and is charted in Fig. 
7 in relation to the time post vaccination that the serum was obtained. Fig. 7 
shows the relationship to time post vaccination of the factor for the log hemag- 
glutination inhibition  titer  minus  the  log virus  neutralization titer.  If both 
antibody activities had developed at the same rate, the difference factor would 
be the same throughout the period of antibody development; the points would 
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FIo. 7. Curve indicating the effect of interval post vaccination upon the difference between 
log values for two antibody activities as an expression of the difference in rate of development 
and decline of hemagglutination inhibition and virusmeutrali~ing antibody. 
then have described a line parallel to the horizontal lines drawn in Fig. 7. It is 
evident that the difference factor, plotted as a function of time does not describe 
a horizontal line in the first 12 week period post vaccination. In this period the 
hemagglutination-inhibiting antibody activity developed  more  rapidly  than 
virus-neutralizing activity; in  the  later  period  the  indications  are  that the 
hemagglutination-inhibiting titer may have declined more slowly. The  latter 
conclusion might be questioned in view  of the very slight degree of variation 
from the parallel line drown at 1.0 log on the negative side of the scale were it 
not for the consistency of the trend both in the monkey vaccinated with virus 
and adjuvant and in the animal given virus in saline. Fig. 8 indicates in a similar 
manner  the  independence of  the  factors for hemagglutination-inhibiting ac- ~ONAS  ~.  SALK AND  ANGELA  M.  LAIYRENT  443 
tivity and complement-fixing activity; corresponding data are available indi- 
cating  the independence of the virus-neutralizing and  complement-fixing ac- 
tivities. 
The results of other experiments on the question of the relationship of the 
different antibody activities of the serum of animals immunized with influenza 
viruses are to be reported. The observations described here confirm still others 
made earlier (16, 17), in the course of studies on immunization of mice in which 
it was found that hemagglutination-inhibiting activity appeared more rapidly 
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FIG. 8. Curve indicating the effect of interval post vaccination  upon the difference  between 
log values for two antibody activities as an expression  of the difference  in rate of development 
and decline of hemagglutination inhibition and complement-fixing  antibody. 
than virus-neutraIizing activity. The latter observations  (16)  were made not 
only with another animal species but with a type B strain (Lee) as well as with 
type A strains. Walker and Horsfall (18), employing a different approach, have 
presented evidence indicating that the virus-neutralizing and hemagglutination- 
inhibiting activities of serum  could be differentially absorbed by interacting 
graded quantities of virus with immune serum; they concluded that  the two 
antibodies are not identical. 
Thus, it has been established that  the enhancement in antibody formation 
induced by vaccination with virus emulsified with mineral oil  influences the 
virus-neutralizing and the complement-fixing activities as well as hemaggluti- 444  ADJUVANTS IN INFLUENZA  IMMUNIZATION 
nation inhibition activity of the serum of vaccinated animals. Careful analysis 
of the rates of development and decline of the three different properties  of 
serum indicates that they are independent functions and if not associated with 
different components of the serum separable one from the other, they are at 
least induced by different components of the antigenic complex of which the 
influenza virus is composed. It is apparent that much more need be done to 
clarify our understanding of the underlying factors and that this can probably 
be done only through the successful dissection of the influenza viruses in a man- 
ner similar to that which has been applied to the separation of the various anti- 
genic components of many bacteria and of certain viruses, notably vaccinia. 
Studies are in progress to determine which, if any, of the antibodies are directly 
related to immunity to infection. 
DISCUSSION 
In the studies here reported untoward local reactions were not observed fol- 
lowing inoculation of monkeys with influenza virus vaccine with a mineral oil 
adjuvant.  Nevertheless,  there  occurred  a  marked enhancement in  antigenic 
effect. It is desired, therefore, to emphasize the particular features of the present 
investigations that are different from those reported by others in which inocu- 
lation  of mineral oil  adjuvant with or without acid-fast bacilli resulted  in 
undesirable reactions at the site of inoculation. 
It is believed that several considerations account for the differences in the 
observations of the present and previous studies. Contributing factors include 
the use of an emulsifying agent that is non-irritating, a mineral oil of low vis- 
cosity, and an antigen, at least in the concentrations employed, that did not 
induce an inflammatory reaction; a matter of considerable importance was the 
introduction of the inoculum intramuscularly. The use of the muscular rather 
than the subcutaneous depot promotes, by muscular action, the dispersion of 
the emulsion into numerous small droplets; when introduced subcutaneously 
the inoculum tends to remain localized with resulting nodule or cyst formations. 
Acid-fast bacilli were not incorporated into the emulsions used in these studies. 
The immunologic phases of these investigations indicate that rather minute 
quantities of antigen, when incorporated with mineral oil, are still effective in 
antibody  formation.  Thus,  approximately  1,000- to  10,000-fold  less  virus, 
beyond the point of antigenic extinction of virus in saline, is still active antigeni- 
cally when combined with mineral oil. The reason for the much greater im- 
munologic efficiency of virus  plus adjuvant is  suggested  by  several  diverse 
observations, ttistologic findings and the results of certain other investigations 
employing radioactive isotopes indicate not only a prolonged retention of the 
antigen at the inoculation site but also the aggregation around the oily droplets 
of large numbers of lymphocytes and other mononuclear elements. From what 
is known about the mechanism of antibody formation, it would appear that JONAS  E.  SALK  AND  ANGELA  M.  LAURENT  445 
certain chemical and physical attributes of the mixture injected exert a tropic 
influence upon the wandering  cells active in antibody formation. It may be 
postulated that, as a result of the accumulation around the emulsion of cells 
which probably play a part in antibody formation, there is created what might 
be referred to as an antibody producing organ. In other words, it is conceived 
that the antigen in oil is retained at the site of inoculation  and antibody pro- 
ducing cells are brought to it by the chemotropic influence of the constituents 
of the emulsion. An aqueous suspension of virus is absorbed rapidly, dissipated 
throughout the body, and destroyed or taken up by various ceils only a few of 
which may be active in antibody formation. According to this hypothesis,  it is 
readily apparent that whatever quantity of antigen is administered  would be 
utilized more efficiently if injected as an emulsion with a  suitable  adjuvant 
rather than in an aqueous menstruum. 
The  demonstration  that  antibody activities measured by  three  different 
methods develop at different rates and that each probably declines at a rate 
independent of one  another,  makes it  all  the more imperative to establish 
which if any of these activities parallel  the level of immunity that develops 
after vaccination. It is clear that one can no longer speak of influenza antibody; 
it is necessary to refer to the method used in its determination. 
The methods employed  for characterizing  the dimensions of antigenicity of 
the virus studied in these  experiments  may be  used  for establishing  similar 
facts for other viruses that might be considered for incorporation  in a vaccine. 
Employing techniques  similar in principle to those used in these studies,  it is 
already apparent that vast differences exist in the antigenic capacity of differ- 
ent strains of influenza virus and also among different antigens that may be 
present in a single mixture. The practical considerations involved in immuniza- 
tion of man or animals call for quantitative expressions of level and duration 
of persistence  of antibody or immunity. The results of the experiments  here 
reported indicate that it may be possible with the aid of mineral oil adjuvants to 
produce effective levels of antibody and, perhaps, immunity by the use of much 
smaller quantities of antigen than heretofore  considered. Under the latter cir- 
cumstances,  it will become desirable  to know something about the antigenic 
extinction end-point of a particular antigen when combined  with mineral oil 
so as to permit the development not only of the most effective preparation for 
immunization but the safest and most efficient. It is equally evident that by 
reducing  the quantity of any one antigen in a mixture that might be used for 
immunization, it might then be possible to incorporate  other antigens as well 
and then ultimately reduce the number of immunizing injections necessary to 
create and maintain immunity for the various infectious diseases to which man 
and animals are susceptible.  The extension  of these studies in man and other 
animals is  under way and the results  of these investigations  are soon to be 
reported. 446  ADJIYVANT$ IN INFLUENZA  FM~FNIZATION 
Untoward reactions at the site of inoculation were not observed in monkeys 
vaccinated with influenza virus incorporated in a water-in-oil emulsion without 
acid-fast bacilli. 
Studies were then made to measure some d  the dimensions of antigenicity 
of these emulsions to evaluate the extent of the immunologic adjuvant effect. 
This included measurements of height and persistence of the antibody response 
to inoculation and measurements of the extent to which the vaccine could be 
diluted and still induce antibody formation; i.e., antigenic extinction. In addi- 
tion, comparisons were made of the rates of development of hemagglutination- 
inhibiting,  vLms-neutralizing, and  complement-~ing  antibody  activities  to 
determine the relationship among these three properties of the serum of hnmu- 
nized animals. 
It was found that levels of antibody many fold higher were induced by the 
vh-us-adjuvant mixtures as compared with virus in an aqueous menstruum, and 
that the level of antibody induced was related to the quantity of antigen in- 
corporated in the emulsion. The stock vaccine when emulsified could be diluted 
100,000-fold  and was  still active  in  antibody formation whereas  a  100-fold 
dilution  of  the  antigen  without  emulsification  was  essentially  ineffective. 
Equivalent quantities of vLrus in 0.I ml. or 1.0 ml. of emulsion induced anti- 
body responses that were indistinguishable with respect to level or persistence. 
In compa~g the course of antibody development it was found that hemag- 
glutination-inhibiting, virus-neutralizing, and complement-fixing antibodies de- 
velop at different rates; careful analysis of the data derived from the present 
study together with other observations warrant the conclusion that these anti- 
body activities are not present in constant proportion and are independent of 
one another, The implications of this observation and of the others mentioned 
above are discussed. 
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